AU3125695A - Neurologically active aminosteroids - Google Patents
Neurologically active aminosteroidsInfo
- Publication number
- AU3125695A AU3125695A AU31256/95A AU3125695A AU3125695A AU 3125695 A AU3125695 A AU 3125695A AU 31256/95 A AU31256/95 A AU 31256/95A AU 3125695 A AU3125695 A AU 3125695A AU 3125695 A AU3125695 A AU 3125695A
- Authority
- AU
- Australia
- Prior art keywords
- aminosteroids
- neurologically active
- neurologically
- active
- active aminosteroids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27863394A | 1994-07-21 | 1994-07-21 | |
| US278633 | 1994-07-21 | ||
| US36181894A | 1994-12-22 | 1994-12-22 | |
| US361818 | 1994-12-22 | ||
| US47387395A | 1995-06-07 | 1995-06-07 | |
| PCT/US1995/008646 WO1996003421A1 (en) | 1994-07-21 | 1995-07-18 | Neurologically active aminosteroids |
| US473873 | 2006-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3125695A true AU3125695A (en) | 1996-02-22 |
Family
ID=27403009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU31256/95A Abandoned AU3125695A (en) | 1994-07-21 | 1995-07-18 | Neurologically active aminosteroids |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2002500616A (en) |
| AU (1) | AU3125695A (en) |
| WO (1) | WO1996003421A1 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100359556B1 (en) * | 1994-09-01 | 2002-12-18 | 파마시아 앤드 업존 캄파니 | Cosolvent parenteral formulation of tirilazad |
| AU2012323888A1 (en) | 2011-10-14 | 2014-05-29 | Sage Therapeutics, Inc. | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| RU2681835C2 (en) | 2012-01-23 | 2019-03-13 | Сейдж Терапьютикс, Инк. | Neuroactive steroid formulations and methods of treating cns disorders |
| IL294306B2 (en) | 2012-08-21 | 2024-01-01 | Sage Therapeutics Inc | Treatment methods for epilepsy and status epilepticus |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| CN117304245A (en) | 2013-04-17 | 2023-12-29 | 萨奇治疗股份有限公司 | Neuroactive 19-norsteroids and methods of use |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| BR112015026380A8 (en) | 2013-04-17 | 2019-12-31 | Sage Therapeutics Inc | 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of using these |
| AU2014290400B2 (en) | 2013-07-19 | 2019-12-05 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| EP3488852B1 (en) | 2013-08-23 | 2020-10-28 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (en) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | Neuroactive steroids and formulations, and their uses |
| AU2015331597B2 (en) | 2014-10-16 | 2020-04-30 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| CN117024502A (en) | 2014-10-16 | 2023-11-10 | 萨奇治疗股份有限公司 | Compositions and methods for targeting CNS disorders |
| EP3719029A1 (en) | 2014-11-27 | 2020-10-07 | Sage Therapeutics, Inc. | Compositions for inducing sedation |
| DK3250210T3 (en) | 2015-01-26 | 2021-03-08 | Sage Therapeutics Inc | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS |
| WO2016134301A2 (en) | 2015-02-20 | 2016-08-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| KR20220084418A (en) | 2016-03-08 | 2022-06-21 | 세이지 테라퓨틱스, 인크. | Neuroactive steroids, compositions, and uses thereof |
| NZ749664A (en) | 2016-07-11 | 2025-08-29 | Sage Therapeutics Inc | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| JP7065825B2 (en) | 2016-07-11 | 2022-05-12 | セージ セラピューティクス, インコーポレイテッド | C7, C12, and C16 replacement neurostimulatory steroids and how to use them |
| AR119047A1 (en) | 2019-05-31 | 2021-11-17 | Sage Therapeutics Inc | NEUROACTIVE STEROIDS AS GABAA MODULATORS AND THEIR USE IN THE TREATMENT OF CNS DISORDERS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987001706A2 (en) * | 1985-09-12 | 1987-03-26 | The Upjohn Company | C20 through c26 amino steroids |
| JP2832632B2 (en) * | 1990-05-18 | 1998-12-09 | 本田技研工業株式会社 | Transmission in motorcycle |
-
1995
- 1995-07-18 AU AU31256/95A patent/AU3125695A/en not_active Abandoned
- 1995-07-18 WO PCT/US1995/008646 patent/WO1996003421A1/en not_active Ceased
- 1995-07-18 JP JP50576096A patent/JP2002500616A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996003421A1 (en) | 1996-02-08 |
| JP2002500616A (en) | 2002-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1385195A (en) | Pesticides | |
| AU3304795A (en) | Bisresorcinyltriazines | |
| AU2832295A (en) | Cytoanalyzer | |
| AU3304995A (en) | 2-Hydroxyphenyltriazines | |
| AU3125695A (en) | Neurologically active aminosteroids | |
| EP0688698A3 (en) | Vehicle network | |
| AU2837895A (en) | Thiazine- or thiazepine-derivatives | |
| AU2308295A (en) | Heterocyclylbenzonitriles | |
| AU3554995A (en) | Antipicornaviral agents | |
| AU1963395A (en) | Boom-structure | |
| AU3166195A (en) | Acylimidazopyridines | |
| AU1716895A (en) | Vs ribozymes | |
| AU1093697A (en) | Active bio-compounds | |
| AU2411395A (en) | Hydrocopter | |
| AU1603595A (en) | Meso-azanoradamantanes | |
| AU3166095A (en) | Benzylimidazopyridines | |
| AU4783896A (en) | Active bio-compounds | |
| AU3417395A (en) | Hydro-ethano-indeno-pyridines | |
| AU653704B3 (en) | Aperture former | |
| AU3923995A (en) | Active bio-compounds | |
| AUPM566094A0 (en) | Aperture former | |
| AUPM757394A0 (en) | Ground-engaging structure | |
| AUPM498194A0 (en) | Calling aid | |
| HK31794A (en) | Eyedrops | |
| AUPM383894A0 (en) | Garrow-polygonal arrow |